Overview
Marion Scharpfenecker practices in Leiden, Netherlands. Scharpfenecker is rated as an Experienced expert by MediFind in the treatment of Minimal Change Disease. Their top areas of expertise are Focal Segmental Glomerulosclerosis, Diabetic Nephropathy, Glomerulonephritis, and Wilson Disease.
Their clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Minimal Change Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Focal Segmental GlomerulosclerosisScharpfenecker isDistinguished. Learn about Focal Segmental Glomerulosclerosis.
- Advanced
- Diabetic NephropathyScharpfenecker isAdvanced. Learn about Diabetic Nephropathy.
- Experienced
- Autosomal Dominant Polycystic Kidney DiseaseScharpfenecker isExperienced. Learn about Autosomal Dominant Polycystic Kidney Disease.
- Chronic Kidney DiseaseScharpfenecker isExperienced. Learn about Chronic Kidney Disease.
- End-Stage Renal Disease (ESRD)Scharpfenecker isExperienced. Learn about End-Stage Renal Disease (ESRD).
- GlomerulonephritisScharpfenecker isExperienced. Learn about Glomerulonephritis.
- Minimal Change DiseaseScharpfenecker isExperienced. Learn about Minimal Change Disease.
- Polycystic Kidney DiseaseScharpfenecker isExperienced. Learn about Polycystic Kidney Disease.